Stem-like T cells in cancer and autoimmunity

Area of Science:

• Immunology
• Cell Biology
• Cancer Research
• Autoimmunity

Background:

• Stem-like T cells exhibit self-renewal and long-term survival, generating diverse effector and memory T cell populations.
• Recent single-cell RNA-sequencing (scRNA-seq) and lineage tracing highlight their critical roles in cancer and autoimmunity.
• These cells are key players in anti-tumor immunity and can drive autoimmune pathology by maintaining autoreactive cell pools.

Purpose of the Study:

• To review the discovery and functions of stem-like T cells in cancer and autoimmunity.
• To summarize the impact of microbiota and metabolism on stem-like T cell populations.
• To discuss the clinical implications of stem-like T cell research for treating cancer and autoimmune diseases.

Main Methods:

• Literature review of recent advances in immunology and cell biology.
• Analysis of single-cell RNA-sequencing (scRNA-seq) and lineage tracing studies.
• Synthesis of findings on microbiota, metabolism, and T cell populations.

Main Results:

• Stem-like T cells are essential for anti-tumor responses by generating tumor-controlling effector T cells.
• In autoimmunity, they contribute to disease by sustaining long-lived autoreactive cells.
• Microbiota and metabolism significantly influence the stem-like T cell pool.

Conclusions:

• Stem-like T cells have a dual role, beneficial in cancer and detrimental in autoimmunity.
• Targeting stem-like T cells offers potential for novel cancer and autoimmune disease treatments.
• Further research into microbiota and metabolic influences can refine therapeutic strategies.